Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

When compared to its XBB vaccine, Pfizer’s KP.2 COVID-19 vaccine offered up to a 7.3-times stronger response in mice infected with KP.2 and several other JN variants, according to trial data.